Last €42.19 EUR
Change Today +0.24 / 0.57%
Volume 200.0
As of 1:54 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Lynn Seely M.D.

Chief Medical Officer and Senior Vice President, Medivation, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

54$3,058,474
As of Fiscal Year 2012

Background*

Dr. Lynn Seely, M.D. has been the Chief Medical Officer of Medivation, Inc. (Formerly Orion Acquisition Corp. II) since May 9, 2005 and has been its Senior Vice President since January 2009. Dr. Seely is responsible for the strategy and execution of Orion Acquisition Corp. II's clinical development programs, and for assisting in the evaluation of new opportunities to expand. Dr. Seely served as Vice President of Clinical Development at Corgentech Inc., from 2002 to 2005, ...

Read Full Background

Corporate Headquarters*

525 Market Street
San Francisco, California 94105

United States

Phone: 415-543-3470
Fax: 415-543-3411

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Oklahoma City University
MD
College of Medicine at the University of Oklahoma

Other Affiliations*

Annual Compensation*

Salary$464,200
Total Annual Compensation$464,200

Stock Options*

Restricted Stock Awards$483,120
All Other Compensation$11,518
Exercised Options417,000
Exercised Options Value$13,444,259
Exercisable Options383,849
Exercisable Options Value$14,960,302
Unexercisable Options225,551
Unexercisable Options Value$6,049,202
Total Value of Options$34,453,763
Total Number of Options1,026,400

Total Compensation*

Total Annual Cash Compensation$1,032,718
Total Short Term Compensation$464,200
Other Long Term Compensation$494,638
Total Calculated Compensation$3,058,474
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WMD:GR €42.19 EUR +0.24

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Arena Pharmaceuticals, Inc.
$690.0K
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics Inc.
$724.4K
Daniel G. Welch Chairman, Chief Executive Officer and President
InterMune, Inc.
$703.4K
Shailesh Ayyangar B.V.Fc & A.H., P.G.D.M.Managing Director, Vice President of South Asia - Global Operations, Executive Director and Member of Audit Committee
Sanofi India Limited
8.6M
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
$1.0M
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIVATION INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.